Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality8/10

Milestone Scientific posts 231% medical growth; expands federal distribution

Aug 14, 2026, 7:36 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Positive mix shift in medical segment, payor reimbursement progress, and a federal distribution deal create near-term upside; however, the small base and Q3 seasonality temper immediate upside.

AI summary

What happened, with direct paths to the underlying reporting

Milestone Scientific reported Q2 2026 revenue of $2.8M, up 22% YoY, with six-month revenue of $5.0M, up 9.8%. CompuFlo revenue surged 230% YoY, aided by payer reimbursement of about $325 per procedure under CPT 0777T. The company reaffirmed 2026 double-digit growth and announced a federal distribution deal and an AI pilot to drive adoption in H2 2026.

Q2 2026 revenue $2.8M; six months $5.0M, up 22.3% and 9.8%.
CompuFlo revenue up 230% YoY; Medicare reimbursement about $325 per CPT 0777T procedure.
Strategic distribution with Red One Medical expands VA/DoD access to over 18 million beneficiaries.
MILO AI platform launched; aims to improve product questions, education, and lead qualification.
Reaffirms 2026 outlook: $9.8–$10.2M revenue; cash burn to improve; breakeven in early 2027.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.